Invasive Fungal Infection
📧 Sign up to get email alerts when something new happens for Invasive Fungal Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation [Phase 3]
Phase 3 trial evaluating rezafungin versus standard antimicrobial prophylaxis to prevent invasive fungal diseases in adults undergoing allog…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: PK/PD of Caspofungin in Children Severe Infection
The document reports an ongoing pediatric pharmacokinetics/pharmacodynamics study of caspofungin in children with severe fungal infection an…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections [Phase 2]
A Phase 2 clinical trial is investigating EL219 versus standard of care for early antifungal therapy in patients with suspected invasive mou…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis
This clinical trial update describes a real-world prospective observational study evaluating the safety and efficacy of liposomal amphoteric…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: De-escalation - Antifungal Treatment Immunocompromised Patients
Clinical trial update on de-escalation of antifungal therapy in immunocompromised patients with invasive fungal infection; the study status …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Immunomonitoring of Mold Invasive Infections
A clinical trial evaluating immunomonitoring of mold invasive fungal infections is currently recruiting, sponsored by Assistance Publique - …
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127) [Phase 2]
A Phase 2 trial (MK-5592-127) is evaluating intravenous and oral posaconazole in children under 2 years with invasive fungal infection, and …
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative
Clinical trial update noting ongoing recruitment for a study assessing the incidence of invasive fungal infections in adults with Ph-negativ…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi [Phase 4]
Phase 4 trial update indicating completion of the study of Pfizer's Cresemba (posaconazole) for invasive fungal disease due to Aspergillus s…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection [Phase 1, Phase 2]
A ongoing Phase 1/2 clinical trial evaluating the safety and efficacy of intravenous BSG005 in patients with invasive fungal infection.
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants [Phase 4]
A Phase 4 clinical trial update evaluating posaconazole pharmacokinetics in patients receiving chemotherapy or stem cell transplants; recrui…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease
A clinical trial update announcing ongoing recruitment to study the efficacy and safety of amphotericin B and azole antifungals for invasive…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant Recipients
A completed clinical trial evaluating diagnostic methods for invasive fungal disease in lung transplant recipients.
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: Registry of Patients Treated With Systemic Mold-Active Triazoles
A completed registry of patients treated with systemic mold-active triazole antifungals for invasive fungal infections, summarizing real-wor…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Multicenter Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant Patients
A multicenter cohort study evaluating invasive filamentous fungal infections in liver transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: A Bioequivalence Study of APX001 High-load and Low-load Tablets [Phase 1]
Phase 1 bioequivalence study comparing high-load and low-load APX001 tablets for invasive fungal infections has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds [Phase 2]
Phase 2 open-label study of APX001 (fosmanogepix) for invasive mold infections including Aspergillus; the trial was terminated and results w…
-
FDA approval · 2022-07-28FDA Approved: POSACONAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for posaconazole delayed-release (POSACONAZOLE DELAYED-RELEASE) from Chartwell RX, LLC, updating its…
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors [Phase 4]
Phase 4 clinical trial evaluating efficacy and safety of Micafungin for Injection to prevent and treat fungal infections in patients with he…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120) [Phase 1]
Phase 1 pharmacokinetics and safety study of intravenous posaconazole (MK-5592) in Chinese participants at high risk for invasive fungal inf…
-
CLINICAL_TRIALS research · 2018-06-19Clinical Trial Update: Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung Transplant [Phase 2]
A Phase 2 clinical trial compares universal prophylaxis with posaconazole versus pre-emptive therapy after lung transplantation. The goal is…
-
CLINICAL_TRIALS trial_result · 2017-07-14Clinical Trial Update: Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117) [Phase 1]
Phase 1 pharmacokinetics and safety study of oral posaconazole (MK-5592) tablets in Chinese participants at high risk for invasive fungal in…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Posaconazole to Treat Invasive Fungal Infections [Phase 3]
Phase 3 trial of posaconazole for invasive fungal infections has completed, involving patients with chronic granulomatous disease and Hyper-…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041) [Phase 3]
Open-label Phase 3 trial evaluating posaconazole for invasive fungal infections has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Pharmacologic Optimization of Voriconazole [Phase 3]
This document reports the completion of a Phase 3 trial evaluating pharmacologic optimization of voriconazole for invasive fungal infections…